Back to
GEODE CAPITAL MANAGEMENT, LLC
CHRS31 quarters
Position history for
GEODE CAPITAL MANAGEMENT, LLC's holdings in COHERUS ONCOLOGY INC
Yes. Geode Capital Management holds 3,685,567 shares of CHRS (Coherus Oncology), worth $5.2M, as of its Q2 2026 13F filing. It increased the position by 563,989 shares (+18.1%) from Q1 2026. Geode Capital Management has held CHRS in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$5.2M
Current Shares
3.7M
Total Value Change
-$543,990
Total Shares Change
+3.1M
Quarter-by-Quarter History
Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP